Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Print
ISSN
1434-6621
See all formats and pricing
More options …
Volume 51, Issue 9

Issues

Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation

Carolien Bonroy / Charlotte Verfaillie / Vanessa Smith / Lies Persijn / Evy De Witte / Filip De Keyser / Katrien Devreese
Published Online: 2013-04-06 | DOI: https://doi.org/10.1515/cclm-2013-0016

Abstract

Background: Screening for antinuclear antibodies (ANA) is a basic tool in the serological work-up of systemic rheumatic disorders. Despite the emergence of alternative screening methods and the difficulties in standardization, indirect immunofluorescence (IIF) remains the recommended method for ANA detection. This study aimed to assess the reliability of automated ANA IIF analysis as a standardized alternative for the conventional manual approach.

Methods: ANA testing on HEp-2000 cells was performed on 304 consecutive routine sera, 28 serumbank samples displaying rare staining patterns, 219 samples of well-defined disease cohorts [141 systemic sclerosis (SSc), 13 polymyalgia rheumatica, 22 osteoarthritis, 5 ANCA-associated vasculitis and 38 spondyloarthritis] and 100 healthy donors. All samples were analyzed by automated IIF (Zenit G-sight), by conventional visual IIF microscopy and two ANA screening enzyme immunoassays (EIA).

Results: Automated and conventional ANA IIF analysis were comparable for negative/positive interpretation as well as intensity assessment (>90% agreement). In contrast, the accuracy of pattern recognition (26%) was limited. Likelihood ratios (LR) for SSc on results intervals of both Zenit G-sight and EIA increased with increasing level of positivity. Sensitivity within the SSc-associated antibody subsets was higher for Zenit G-sight (97%–100%) than EIA (10%–96%). A significant correlation between the quantitative result obtained by Zenit G-sight and the conventional end-point titer was found.

Conclusions: The use of Zenit G-sight for automated ANA IIF analysis offers opportunities to improve standardization. However, a complementary role of the expert technicians remains, especially for pattern recognition and classification of uncertain/negative samples.

This article offers supplementary material which is provided at the end of the article.

Keywords: antinuclear antibodies; automation; enzyme immunoassay; indirect immunofluorescence

References

  • 1.

    Solomon DH, Kavanaugh AJ, Schur PH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434–44.CrossrefPubMedGoogle Scholar

  • 2.

    Bizzaro N, Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004;22:349–55.PubMedGoogle Scholar

  • 3.

    Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71–81.PubMedGoogle Scholar

  • 4.

    Vos PA, Bast EJ, Derksen RH. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. Rheumatology (Oxford) 2006;45:629–35.CrossrefGoogle Scholar

  • 5.

    Kivity S, Gilburd B, Agmon-Levin N, Carrasco MG, Tzafrir Y, Sofer Y, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2012;31:503–9.PubMedCrossrefGoogle Scholar

  • 6.

    Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9:17–22.PubMedWeb of ScienceGoogle Scholar

  • 7.

    Van Praet JT, Vander Cruyssen B, Bonroy C, Smith V, Delanghe J, De Keyser F. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies. Clin Exp Rheumatol 2009;27:971–6.PubMedGoogle Scholar

  • 8.

    Op De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801–8.CrossrefWeb of ScienceGoogle Scholar

  • 9.

    Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420–2.Web of SciencePubMedCrossrefGoogle Scholar

  • 10.

    Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012;11:713–6.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 11.

    Bossuyt X, Cooreman S, De Baere H, Verschueren P, Westhovens R, Blockmans D, et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 2012;415C:101–6.Web of ScienceGoogle Scholar

  • 12.

    Van Praet JT, Van Steendam K, Smith V, De Bruyne G, Mimori T, Bonroy C, et al. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach. Rheumatology 2011;50:1302–9.CrossrefGoogle Scholar

  • 13.

    Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004;63:1155–8.PubMedCrossrefGoogle Scholar

  • 14.

    De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587–93.CrossrefPubMedGoogle Scholar

  • 15.

    Bonroy C, Van Praet J, Smith V, Van Steendam K, Mimori T, Deschepper E, et al. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. J Immunol Methods 2012;379:53–60.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 16.

    Bonroy C, Smith V, Van Steendam K, Van Praet J, Deforce D, Devreese K, et al. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques. Clin Exp Rheumatol 2012;30:748–55.PubMedGoogle Scholar

  • 17.

    Humbel RI. Detection of antiniuclear antibodies by immunofluorescence. In: Van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. Dordrecht: Kluwer Academic, 1993:1–16.Google Scholar

  • 18.

    Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000;45:23–41.CrossrefPubMedGoogle Scholar

  • 19.

    Cohen JA. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46.CrossrefGoogle Scholar

  • 20.

    Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 2009;8:543–8.Web of ScienceCrossrefGoogle Scholar

  • 21.

    Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, Radau B, et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010;12:R40.PubMedWeb of ScienceGoogle Scholar

  • 22.

    Rattner JB, Mack GJ, Fritzler MJ. Autoantibodies to components of the mitotic apparatus. Mol Biol Rep 1998;25:143–55.CrossrefPubMedGoogle Scholar

  • 23.

    Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol 2006;26:438–46.CrossrefGoogle Scholar

About the article

Corresponding author: Carolien Bonroy, Ghent University Hospital (2P8), De Pintelaan 185, 9000 Ghent, Belgium, Phone: +32 9 3323631, Fax: +32 9 3324985


Received: 2013-01-04

Accepted: 2013-03-14

Published Online: 2013-04-06

Published in Print: 2013-09-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 51, Issue 9, Pages 1771–1779, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2013-0016.

Export Citation

©2013 by Walter de Gruyter Berlin Boston.Get Permission

Supplementary Article Materials

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Michelle Elaine Orme, Carmen Andalucia, Sigrid Sjölander, and Xavier Bossuyt
Best Practice & Research Clinical Rheumatology, 2018, Volume 32, Number 4, Page 521
[2]
Clemens Dario Loock, Karl Egerer, Eugen Feist, and Gerd-Rüdiger Burmester
RMD Open, 2017, Volume 3, Number 1, Page e000409
[3]
Anne E. Tebo and Christopher J. Papasian
Clinical and Vaccine Immunology, 2017, Volume 24, Number 12
[4]
Vincent Ricchiuti, Joseph Adams, Donna J. Hardy, Alexander Katayev, and James K. Fleming
Frontiers in Immunology, 2018, Volume 9
[7]
Teresa Carbone, Michele Gilio, Maria Carmela Padula, Giuseppina Tramontano, Salvatore D'Angelo, and Vito Pafundi
Journal of Immunological Methods, 2018
[8]
C Krause, K Ens, K Fechner, J Voigt, J Fraune, E Rohwäder, M Hahn, M Danckwardt, C Feirer, E Barth, T Martinetz, and W Stöcker
Lupus, 2015, Volume 24, Number 4-5, Page 516
[9]
Wymke Hormann, Melanie Hahn, Stefan Gerlach, Nicola Hochstrate, Kai Affeldt, Joyce Giesen, Kai Fechner, and Jan G.M.C. Damoiseaux
Clinical Chemistry and Laboratory Medicine (CCLM), 2017, Volume 0, Number 0
[10]
Bing Zheng, Enling Li, Haoming Zhu, Jingbo Lu, Xinming Shi, Jie Zhang, and Min Li
Clinical Chemistry and Laboratory Medicine (CCLM), 2017, Volume 0, Number 0
[11]
M. Infantino, F. Meacci, V. Grossi, M. Manfredi, M. Benucci, M. Merone, and P. Soda
Immunologic Research, 2017, Volume 65, Number 1, Page 345
[12]
Mohammed Alsuwaidi, Margit Dollinger, Martin Fleck, and Boris Ehrenstein
International Journal of Rheumatology, 2016, Volume 2016, Page 1
[13]
Ishan Nigam, Shreyasi Agrawal, Richa Singh, and Mayank Vatsa
IEEE Access, 2015, Volume 3, Page 3102
[14]
Juliane Scholz, Kai Grossmann, Ilka Knütter, Rico Hiemann, Mandy Sowa, Nadja Röber, Stefan Rödiger, Peter Schierack, Dirk Reinhold, Dimitrios P. Bogdanos, Pier Luigi Meroni, Antonella Radice, Karsten Conrad, and Dirk Roggenbuck
Clinical Chemistry and Laboratory Medicine (CCLM), 2015, Volume 53, Number 12
[15]
Stefan Gerlach, Kai Affeldt, Lena Pototzki, Christopher Krause, Jörn Voigt, Johanna Fraune, and Kai Fechner
Journal of Immunology Research, 2015, Volume 2015, Page 1
[16]
Dirk Roggenbuck, Rico Hiemann, Peter Schierack, Dirk Reinhold, and Karsten Conrad
Clinical Chemistry and Laboratory Medicine (CCLM), 2014, Volume 52, Number 2
[17]
Alireza Ghanadan, Amene Saghazadeh, Issa Jahanzad, and Nima Rezaei
Expert Review of Clinical Immunology, 2015, Volume 11, Number 5, Page 597
[18]
Edda Rohwäder, Michael Locke, Johanna Fraune, and Kai Fechner
Expert Review of Molecular Diagnostics, 2015, Volume 15, Number 4, Page 451
[19]
O. Shovman, N. Agmon-Levin, B. Gilburd, T. Martins, A. Petzold, T. Matthias, and Y. Shoenfeld
Immunologic Research, 2015, Volume 61, Number 1-2, Page 135
[20]
Susan S. Copple, Troy D. Jaskowski, Rashelle Giles, and Harry R. Hill
Journal of Immunology Research, 2014, Volume 2014, Page 1
[21]
Nicola Bizzaro, Antonio Antico, Stefan Platzgummer, Elio Tonutti, Danila Bassetti, Fiorenza Pesente, Renato Tozzoli, Marilina Tampoia, and Danilo Villalta
Autoimmunity Reviews, 2014, Volume 13, Number 3, Page 292

Comments (0)

Please log in or register to comment.
Log in